← All Sponsors
SPONSOR

Brii Biosciences Limited

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Chronic Hepatitis B Virus (HBV) Infection
NCT06650852 Phase 2
Recruiting

A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)

Chronic Hepatitis B Virus (HBV) Infection
China View Trial →